Real-world experiences in patients with Ewing sarcoma treated at a specialist centre in Turkey.

Although a decreasing trend can be seen toward the last decade of our study, a significant proportion of the patients who developed an event refused second-line treatment, and 68 % of those with a local recurrence subsequently died.

also in 47,180 other papers